Stay updated on Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2, likely reflecting minor internal fixes or improvements to the platform.SummaryDifference0.0%

- Check18 days agoChange DetectedNew Turkish study locations (Ankara and Samsun) and a 'Results Posted' entry have been added, and several earlier Turkish sites were removed or updated.SummaryDifference2%

- Check25 days agoChange DetectedAdded the CEPHEUS trial citation from Nat Med (2025) and removed the Erratum notice for that article.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded Results Submitted and Revision: v3.5.0; removed No Results Posted and Revision: v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded Revision: v3.4.3. Removed the topic 'Multiple myeloma' and related topics including 'MedlinePlus Genetics'; also removed 'Revision: v3.4.2'.SummaryDifference0.1%

- Check53 days agoChange Detected- Added related topics entry for multiple myeloma (MedlinePlus Genetics) and the CEPHEUS trial citation. - Removed the duplicate/overlapping citation entry.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.